Welcome to the ADVANZ PHARMA AST Investigational Programme

(ADVANZ PHARMA ASTIP)

coordinated by

ADVANZ PHARMA

Goal of ASTIP

ADVANZ PHARMA offers you the opportunity to join the antimicrobial susceptibility Investigational Program (ASTIP). The ASTIP provides In Vitro Diagnostics (IVD) materials for susceptibility testing at no cost. The goal is to help healthcare institutions to better understand the susceptibility of pathogens, the appropriate use of antibiotics and the prevention of antimicrobial resistances in your healthcare institution. By registering to ASTIP you can order a limited quantity of in vitro testing material for research use only and upload anonymised results. Disks and Strips are manufactured by Liofilchem® s.r.l. (https://www.liofilchem.com) and automated testing plates by Thermo Fisher Scientific (https://www.thermofisher.com)

All the information and personal data you share with us will be protected and kept confidential in line with our company policy on data protection accessible here https://www.advanzpharma.com/privacy-policy. By clicking on the button “Register for Enrollment” or contacting us by phone or at the info@advanz.com address and submitting your personal information as requested in particular in the concerned form you consent to the processing of your personal data in accordance with our privacy policy. The collected information will be used only for the management of your request and will be stored for a limited period, proportionate to the aims pursued. You have a right of access to the personal data which we may hold about you as well as various other rights as outlined in our privacy policy. To exercise any of those rights, or if you have any comments or questions about our privacy policy, you can address your request to the following email address: enquiries@advanz-astip.com.

Ceftobiprole

Ceftobiprole is an advanced-generation cephalosporin with rapid bactericidal activity against Gram-positive and Gram-negative bacteria including MRSA, MSSA, CoNS, Enterococcus faecalis, and Pseudomonas ssp. Ceftobiprole is indicated in Hospital-acquired pneumonia (HAP) excluding ventilator-associated pneumonia (VAP) and Community-acquired pneumonia (CAP). Ceftobiprole is administered intravenously and is the active moity of the prodrug ceftobiprole medocaril.

Dalbavancin

Dalbavancin is the first single-dose, 30-min IV antibiotic for ABSSSI (acute bacterial skin and skin structure infections) providing a full course of treatment. Dalbavancin is a lipoglycopeptide with bactericidal activity against relevant Gram-positive pathogens for ABSSSI including MRSA, MSSA, and CoNS.

Cefepime/Enmetazobactam

Cefepime/Enmetazobactam is a novel and targeted Beta lactam/ Beta lactamase inhibitor combination indicated for the treatment of complicated urinary tract infections, nosocomial pneumonia and bacteremia caused by Gram-negative bacteria. Enmetazobactam restored restores cefepime activity against ESBL-positive isolates and greatly enhanced enhances the activity of cefepime against isolates encoding AmpC, AmpC + ESBL and ESBL + OXA genes. Cefepime/Enmetazobacatm Enmetazobactam (2g/0.5g) is administered intravenously every 8 hours.

User Information

Institution Name*

Prefix

First Name *

First name is required.

Last Name *

Last name is required.

Position *

Position is required.

Department *

Department is required.

Shipping Address1 *

Shipping Address1 is required.

Shipping Address2

Shipping Address1 is required.

Country

Country is required.

State *

State/Region is required.

City *

City is required.

Postal Code *

Postal Code is required.

Your Email *

Your Email is required.

Phone *

Phone is required.

Fax

I have read and agree to the Terms & Conditions

I hereby confirm that the ordered materials will only be used for the purpose of general epidemiological research.

Testing Material Selection

Please select the testing materials you wish to receive.

Requests for Ceftobiprole and Enmetazobactam powder may be sent to clinicaldevelopment@advanzpharma.com

My ADVANZ PHARMA ASTIP Account Creation Details

User Email*

Password*

Confirm Password*

- Ensures at least one lowercase letter.
- Ensures at least one uppercase letter.
- Ensures at least one digit.
- Ensures at least one special character.
- Ensures the password is at least 8 characters long.

Welcome to the ADVANZ PHARMA AST Investigational Programme

(ADVANZ PHARMA ASTIP)

Goal of ASTIP

Ceftobiprole

Dalbavancin

Cefepime/Enmetazobactam

User Information

Testing Material Selection

My ADVANZ PHARMA ASTIP Account Creation Details

My ADVANZ PHARMA ASTIP Access with account

About ADVANZ PHARMA

Address

Useful Link

Help & Support